Educational Disclaimer: This case study is for educational and informational purposes only. It does not constitute medical advice, clinical guidance, or a substitute for professional psychiatric evaluation. All diagnostic criteria referenced are from the DSM-5-TR (APA, 2022). Clinicians should rely on their professional training, direct patient assessment, and current evidence-based guidelines when making diagnostic and treatment decisions.

Clinical Vignette

Patient: "Ms. V," 36-year-old pharmacist, presenting for medication review after 6 separate mood episodes in the past 10 months despite lithium monotherapy.

Chief Concern: "The lithium helped at first but now I'm cycling faster than before. I had 3 depressive episodes and 3 hypomanic episodes since last February. My boss is noticing my performance fluctuations."

History of Present Illness: Ms. V was diagnosed with Bipolar II Disorder at age 28. She was stable on lithium 900mg daily for 3 years. Ten months ago, her cycling pattern accelerated. She has documented 6 distinct episodes: 3 hypomanic episodes (lasting 5-8 days each, characterized by increased energy, decreased sleep need, increased productivity, elevated mood) alternating with 3 major depressive episodes (lasting 2-4 weeks each, with anhedonia, hypersomnia, concentration difficulties, passive suicidal ideation). Between episodes, she has brief periods of euthymia lasting 1-3 weeks. Current lithium level is 0.82 mEq/L (therapeutic). TSH was 6.8 mIU/L (elevated; reference range 0.4-4.0). Free T4: 0.7 ng/dL (low-normal). She takes no other medications. She has been compliant with lithium throughout.

Medical History: Bipolar II Disorder (diagnosed age 28). Current medication: lithium 900mg daily. No other medical conditions. BMI 24. Non-smoker.

Mental Status Exam: Currently in euthymic interval. Alert, cooperative. Speech normal. Mood 'okay for now.' Affect euthymic, appropriate. No suicidal ideation currently. Insight good. Judgment intact.

Step 1: Confirming the Rapid Cycling Specifier

DSM-5-TR defines rapid cycling as a course specifier (not a separate diagnosis) applicable to Bipolar I or Bipolar II when at least 4 mood episodes occur in the previous 12 months. Episodes are demarcated by either a switch to the opposite polarity or by a period of remission of at least 2 months.

Episode count (past 12 months)

Six documented episodes: 3 hypomanic and 3 major depressive. This exceeds the minimum of 4. RAPID CYCLING CONFIRMED.

Episode demarcation

Each episode is separated by either a switch to opposite polarity (hypomania to depression) or a euthymic interval of 1-3 weeks. DSM-5-TR requires either a polarity switch or ≥2-month partial/full remission. Polarity switches satisfy demarcation. MET.

Episode validity

Hypomanic episodes: 5-8 days each (exceeds 4-day minimum), with characteristic Bipolar II hypomanic features. Depressive episodes: 2-4 weeks each (exceed 2-week minimum), with 5+ MDE symptoms. All episodes meet individual criteria. MET.

Step 2: Thyroid Evaluation and Treatment Implications

Thyroid dysfunction has a documented association with mood instability in bipolar disorder. Ms. V's elevated TSH (6.8) indicates subclinical hypothyroidism, which may be contributing to her rapid cycling pattern.

Factor Clinical Significance This Patient
Lithium-induced hypothyroidism Lithium inhibits thyroid hormone synthesis and release. Subclinical hypothyroidism occurs in a significant proportion of lithium-treated patients. TSH 6.8: elevated on lithium. Likely lithium-induced.
Hypothyroidism and rapid cycling Thyroid dysfunction is associated with increased mood cycling frequency. Correction of hypothyroidism may reduce cycle frequency. Subclinical hypothyroidism may be contributing to rapid cycling.
Treatment adjustment Options: add levothyroxine to correct TSH, add/switch mood stabilizer (lamotrigine for depressive pole), optimize lithium. Levothyroxine supplementation indicated. Consider adding lamotrigine.

Treatment Plan

Two interventions are indicated: (1) Start levothyroxine to correct lithium-induced subclinical hypothyroidism, targeting TSH <2.5 mIU/L. (2) Consider adding lamotrigine for depressive pole protection, as lithium shows better efficacy for manic/hypomanic prevention than depressive prevention. Reassess cycling frequency after thyroid normalization.

Diagnostic Formulation

Diagnostic Conclusion

Bipolar II Disorder, with Rapid Cycling specifier (F31.81): Bipolar II confirmed (hypomanic episodes without mania). Six episodes in 10 months satisfies the ≥4 episodes/12 months rapid cycling threshold. Subclinical hypothyroidism (TSH 6.8, likely lithium-induced) may be a contributing factor. Treatment plan: thyroid supplementation + mood stabilizer augmentation.

Teaching Points

  • Rapid cycling is a course specifier, not a subtype. It can apply to any patient with Bipolar I or Bipolar II during periods when cycling frequency increases. A patient may have rapid cycling during one period and non-rapid cycling during another.
  • The minimum threshold is 4 episodes in 12 months. Some patients cycle even faster (ultra-rapid cycling: episodes lasting days to weeks; ultradian cycling: mood shifts within a single day). DSM-5-TR recognizes only the ≥4/year threshold as the formal specifier.
  • Thyroid function should be monitored regularly in all lithium-treated patients. Lithium inhibits thyroid hormone synthesis, and subclinical hypothyroidism is common. Correcting thyroid dysfunction can reduce cycling frequency independently of other interventions.
  • Antidepressant use is controversial in rapid cycling bipolar disorder. Antidepressants may accelerate cycling (switching from depression to hypomania/mania). If an antidepressant is used, it should always be co-prescribed with a mood stabilizer and used for the shortest effective duration.
  • Lamotrigine has the strongest evidence base for preventing depressive episodes in Bipolar II. Its combination with lithium (which is stronger for preventing hypomania/mania) provides complementary coverage of both mood poles.